Delhi Capitals announce Cipla Health’s Maxirich as Official Immunity Partner

New Delhi, 05 April 2021: Maxirich, a daily health supplement from Cipla Health, was today announced as the official immunity partner of Delhi Capitals for the upcoming season of the Indian Premier League (IPL). The JSW and GMR co-owned franchise announced that the multi-vitamin supplement will begin a one-year association with the team.

 

Commenting on the collaboration, Mr. Shivam Puri, CEO, Cipla Health Ltd. said, “At Cipla Health, we are relentlessly working to provide our consumers with the best possible healthcare solutions. IPL being one of the widely watched sporting events in our country, we are very excited about this collaboration with Delhi Capitals IPL franchise and are looking forward to a successful partnership. The Delhi Capitals have proved themselves to be one of the fastest growing franchise of the Indian Premier League. This partnership is testimony to Maxirich’s commitment to boosting the country’s immunity and enabling Indians to stay fit with Maxirich - Immunity Ka Daily Dose"

 

“We are delighted to announce Maxirich as our Official Immunity Partner,” says Delhi Capitals CEO Vinod Bisht. “Good health and strong immunity are of paramount importance in the ongoing pandemic. Delhi Capitals is committed towards safeguarding the health and wellness of our players and support staff, and Maxirich will help us ensure the same. I would like to thank everyone at Maxirich for extending their support to the team’s ambition of winning the coveted trophy."

Maxirich is a blend of 13+ essential vitamins and minerals in a softgel capsule that helps supplement one’s daily diet. It also contains Vitamin D that boosts immunity, while Vitamin B Complex reduces tiredness and fatigue. These vitamins combined with antioxidants and other necessary minerals ensure that the body’s nutrient needs are met, particularly in today’s day and age where daily diets often fall short due to hectic lifestyles and unhealthy eating habits.  

Delhi Capitals announce Cipla Health’s Maxirich as Official Immunity Partner

New Delhi, 05 April 2021: Maxirich, a daily health supplement from Cipla Health, was today announced as the official immunity partner of Delhi Capitals for the upcoming season of the Indian Premier League (IPL). The JSW and GMR co-owned franchise announced that the multi-vitamin supplement will begin a one-year association with the team.

 

Commenting on the collaboration, Mr. Shivam Puri, CEO, Cipla Health Ltd. said, “At Cipla Health, we are relentlessly working to provide our consumers with the best possible healthcare solutions. IPL being one of the widely watched sporting events in our country, we are very excited about this collaboration with Delhi Capitals IPL franchise and are looking forward to a successful partnership. The Delhi Capitals have proved themselves to be one of the fastest growing franchise of the Indian Premier League. This partnership is testimony to Maxirich’s commitment to boosting the country’s immunity and enabling Indians to stay fit with Maxirich - Immunity Ka Daily Dose"

 

“We are delighted to announce Maxirich as our Official Immunity Partner,” says Delhi Capitals CEO Vinod Bisht. “Good health and strong immunity are of paramount importance in the ongoing pandemic. Delhi Capitals is committed towards safeguarding the health and wellness of our players and support staff, and Maxirich will help us ensure the same. I would like to thank everyone at Maxirich for extending their support to the team’s ambition of winning the coveted trophy."

Maxirich is a blend of 13+ essential vitamins and minerals in a softgel capsule that helps supplement one’s daily diet. It also contains Vitamin D that boosts immunity, while Vitamin B Complex reduces tiredness and fatigue. These vitamins combined with antioxidants and other necessary minerals ensure that the body’s nutrient needs are met, particularly in today’s day and age where daily diets often fall short due to hectic lifestyles and unhealthy eating habits.  

Your Comments